AMICAR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Amicar, and when can generic versions of Amicar launch?
Amicar is a drug marketed by Epic Pharma Llc and Hikma and is included in three NDAs.
The generic ingredient in AMICAR is aminocaproic acid. There are six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the aminocaproic acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amicar
A generic version of AMICAR was approved as aminocaproic acid by LUITPOLD on December 1st, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMICAR?
- What are the global sales for AMICAR?
- What is Average Wholesale Price for AMICAR?
Summary for AMICAR
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 183 |
| Clinical Trials: | 12 |
| Drug Prices: | Drug price information for AMICAR |
| What excipients (inactive ingredients) are in AMICAR? | AMICAR excipients list |
| DailyMed Link: | AMICAR at DailyMed |
Recent Clinical Trials for AMICAR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Universidad Autonoma de Nuevo Leon | Phase 2 |
| The University of Texas Health Science Center at San Antonio | Phase 1 |
| Duke University | Phase 4 |
Pharmacology for AMICAR
| Drug Class | Antifibrinolytic Agent |
| Physiological Effect | Decreased Fibrinolysis |
US Patents and Regulatory Information for AMICAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma Llc | AMICAR | aminocaproic acid | INJECTABLE;INJECTION | 015229-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | AMICAR | aminocaproic acid | TABLET;ORAL | 015197-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | AMICAR | aminocaproic acid | SOLUTION;ORAL | 015230-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | AMICAR | aminocaproic acid | TABLET;ORAL | 015197-002 | Jun 24, 2004 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
